BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

766 related articles for article (PubMed ID: 26116801)

  • 1. Allogeneic Bone Marrow-Derived Mesenchymal Stromal Cells Promote Healing of Refractory Perianal Fistulas in Patients With Crohn's Disease.
    Molendijk I; Bonsing BA; Roelofs H; Peeters KC; Wasser MN; Dijkstra G; van der Woude CJ; Duijvestein M; Veenendaal RA; Zwaginga JJ; Verspaget HW; Fibbe WE; van der Meulen-de Jong AE; Hommes DW
    Gastroenterology; 2015 Oct; 149(4):918-27.e6. PubMed ID: 26116801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn's disease: a phase 3 randomised, double-blind controlled trial.
    Panés J; García-Olmo D; Van Assche G; Colombel JF; Reinisch W; Baumgart DC; Dignass A; Nachury M; Ferrante M; Kazemi-Shirazi L; Grimaud JC; de la Portilla F; Goldin E; Richard MP; Leselbaum A; Danese S;
    Lancet; 2016 Sep; 388(10051):1281-90. PubMed ID: 27477896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term Efficacy and Safety of Stem Cell Therapy (Cx601) for Complex Perianal Fistulas in Patients With Crohn's Disease.
    Panés J; García-Olmo D; Van Assche G; Colombel JF; Reinisch W; Baumgart DC; Dignass A; Nachury M; Ferrante M; Kazemi-Shirazi L; Grimaud JC; de la Portilla F; Goldin E; Richard MP; Diez MC; Tagarro I; Leselbaum A; Danese S;
    Gastroenterology; 2018 Apr; 154(5):1334-1342.e4. PubMed ID: 29277560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autologous bone marrow-derived mesenchymal stromal cells in the treatment of fistulising Crohn's disease.
    Ciccocioppo R; Bernardo ME; Sgarella A; Maccario R; Avanzini MA; Ubezio C; Minelli A; Alvisi C; Vanoli A; Calliada F; Dionigi P; Perotti C; Locatelli F; Corazza GR
    Gut; 2011 Jun; 60(6):788-98. PubMed ID: 21257987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term Evaluation of Allogeneic Bone Marrow-derived Mesenchymal Stromal Cell Therapy for Crohn's Disease Perianal Fistulas.
    Barnhoorn MC; Wasser MNJM; Roelofs H; Maljaars PWJ; Molendijk I; Bonsing BA; Oosten LEM; Dijkstra G; van der Woude CJ; Roelen DL; Zwaginga JJ; Verspaget HW; Fibbe WE; Hommes DW; Peeters KCMJ; van der Meulen-de Jong AE
    J Crohns Colitis; 2020 Jan; 14(1):64-70. PubMed ID: 31197361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of Injection of Freshly Collected Autologous Adipose Tissue Into Perianal Fistulas in Patients With Crohn's Disease.
    Dige A; Hougaard HT; Agnholt J; Pedersen BG; Tencerova M; Kassem M; Krogh K; Lundby L
    Gastroenterology; 2019 Jun; 156(8):2208-2216.e1. PubMed ID: 30772343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Standardization of mesenchymal stromal cell therapy for perianal fistulizing Crohn's disease.
    Molendijk I; van der Meulen-de Jong AE; Verspaget HW; Veenendaal RA; Hommes DW; Bonsing BA; Peeters KCMJ
    Eur J Gastroenterol Hepatol; 2018 Oct; 30(10):1148-1154. PubMed ID: 30095479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phase I/II clinical trial of ex-vivo expanded human bone marrow derived allogeneic mesenchymal stromal cells in adult patients with perianal fistulizing Crohn's Disease.
    Swaroop S; Vuyyuru SK; Kante B; Kumar P; Mundhra SK; Arora U; Goyal A; Kandasamy D; Sharma R; Kabilan K; Kedia S; Dash NR; Ahuja V
    Stem Cell Res Ther; 2024 May; 15(1):140. PubMed ID: 38745184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness and safety of local adalimumab injection in patients with fistulizing perianal Crohn's disease: a pilot study.
    Tonelli F; Giudici F; Asteria CR
    Dis Colon Rectum; 2012 Aug; 55(8):870-5. PubMed ID: 22810472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesenchymal stem-cell therapy for perianal fistulas in Crohn's disease: a systematic review and meta-analysis.
    Cheng F; Huang Z; Li Z
    Tech Coloproctol; 2019 Jul; 23(7):613-623. PubMed ID: 31286287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment effect of ex vivo expanded allogeneic bone marrow-derived mesenchymal stem cells for the treatment of fistulizing Crohn's disease are durable at 12 months.
    Lightner AL; Pineiro AO; Reese J; Ream J; Nachand D; Adams AC; Dadgar N; Hull T
    Surgery; 2024 Apr; 175(4):984-990. PubMed ID: 38097485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Phase IB/IIA Study of Allogeneic, Bone Marrow-derived, Mesenchymal Stem Cells for the Treatment of Refractory Ileal-anal Anastomosis and Peripouch Fistulas in the Setting of Crohn's Disease of the Pouch.
    Lightner AL; Reese J; Ream J; Nachand D; Jia X; Pineiro AO; Dadgar N; Steele S; Hull T
    J Crohns Colitis; 2023 Apr; 17(4):480-488. PubMed ID: 36322714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of perianal fistulas in Crohn's disease by local injection of antibody to TNF-alpha accounts for a favourable clinical response in selected cases: a pilot study.
    Asteria CR; Ficari F; Bagnoli S; Milla M; Tonelli F
    Scand J Gastroenterol; 2006 Sep; 41(9):1064-72. PubMed ID: 16938720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Darvadstrocel for Complex Perianal Fistulas in Japanese Adults with Crohn's Disease: A Phase 3 Study.
    Furukawa S; Mizushima T; Nakaya R; Shibata M; Yamaguchi T; Watanabe K; Futami K
    J Crohns Colitis; 2023 Apr; 17(3):369-378. PubMed ID: 36149832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Local application of adipose-derived mesenchymal stem cells supports the healing of fistula: prospective randomised study on rat model of fistulising Crohn's disease.
    Ryska O; Serclova Z; Mestak O; Matouskova E; Vesely P; Mrazova I
    Scand J Gastroenterol; 2017 May; 52(5):543-550. PubMed ID: 28116942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biological immunomodulators improve the healing rate in surgically treated perianal Crohn's fistulas.
    El-Gazzaz G; Hull T; Church JM
    Colorectal Dis; 2012 Oct; 14(10):1217-23. PubMed ID: 22251452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Phase I Study of Ex Vivo Expanded Allogeneic Bone Marrow-Derived Mesenchymal Stem Cells for the Treatment of Pediatric Perianal Fistulizing Crohn's Disease.
    Lightner AL; Otero-Pineiro A; Reese J; Ream J; Nachand D; Adams AC; VanDenBossche A; Kurowski JA
    Inflamm Bowel Dis; 2023 Dec; 29(12):1912-1919. PubMed ID: 37263018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adalimumab combined with ciprofloxacin is superior to adalimumab monotherapy in perianal fistula closure in Crohn's disease: a randomised, double-blind, placebo controlled trial (ADAFI).
    Dewint P; Hansen BE; Verhey E; Oldenburg B; Hommes DW; Pierik M; Ponsioen CI; van Dullemen HM; Russel M; van Bodegraven AA; van der Woude CJ
    Gut; 2014 Feb; 63(2):292-9. PubMed ID: 23525574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesenchymal stromal cells in the treatment of perianal fistulas in Crohn's disease.
    Castro-Poceiro J; Fernández-Clotet A; Panés J
    Immunotherapy; 2018 Oct; 10(14):1203-1217. PubMed ID: 30296868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Healing of transsphincteric perianal fistulas in Crohn's disease using a new technique.
    Winter AM; Banks PA; Petros JG
    Am J Gastroenterol; 1993 Dec; 88(12):2022-5. PubMed ID: 8249967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.